The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
Heterobicyclic Metalloprotease Inhibitors
申请人:STEENECK Christoph
公开号:US20090312312A1
公开(公告)日:2009-12-17
The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
US7795245B2
申请人:——
公开号:US7795245B2
公开(公告)日:2010-09-14
NOVEL HETEROARYL-UREA COMPOUNDS AS KV7.2 INHIBITORS
申请人:[en]ICAGEN, LLC
公开号:WO2023091554A1
公开(公告)日:2023-05-25
The invention provides new heteroaromatic compounds having the general formula (I'), or a solvate or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, Y1, Y2, Y3, and n are as defined herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.